145 related articles for article (PubMed ID: 37766699)
1. Longitudinal humoral immune response and maternal immunity in horses after a single live-attenuated vaccination against African horse sickness during the disease outbreak in Thailand.
Kunanusont N; Taesuji M; Kulthonggate U; Rattanamas K; Mamom T; Thongsri K; Phannithi T; Ruenphet S
Vet World; 2023 Aug; 16(8):1690-1694. PubMed ID: 37766699
[TBL] [Abstract][Full Text] [Related]
2. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
[TBL] [Abstract][Full Text] [Related]
3. Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine.
Chaiyabutr N; Wattanaphansak S; Tantilerdcharoen R; Akesowan S; Ouisuwan S; Naraporn D
Vet World; 2022 Oct; 15(10):2365-2375. PubMed ID: 36425136
[TBL] [Abstract][Full Text] [Related]
4. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
[TBL] [Abstract][Full Text] [Related]
5. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
[TBL] [Abstract][Full Text] [Related]
7. Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1.
Wang Y; Ong J; Ng OW; Songkasupa T; Koh EY; Wong JPS; Puangjinda K; Fernandez CJ; Huangfu T; Ng LC; Chang SF; Yap HH
Emerg Infect Dis; 2022 Dec; 28(12):2446-2454. PubMed ID: 36417933
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to natural rattlesnake envenomation and a rattlesnake toxoid vaccine in horses.
Gilliam LL; Carmichael RC; Holbrook TC; Taylor JM; Ownby CL; McFarlane D; Payton ME
Clin Vaccine Immunol; 2013 May; 20(5):732-7. PubMed ID: 23515015
[TBL] [Abstract][Full Text] [Related]
9. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity for African horse sickness antibodies detection using monovalent and polyvalent vaccine antigen-based dot blotting.
Taesuji M; Rattanamas K; Kulthonggate U; Mamom T; Ruenphet S
Vet World; 2022 Dec; 15(12):2760-2763. PubMed ID: 36718334
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.
Weyer CT; Grewar JD; Burger P; Joone C; Lourens C; MacLachlan NJ; Guthrie AJ
Vaccine; 2017 Apr; 35(18):2504-2510. PubMed ID: 28341113
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
13. A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.
Aksular M; Calvo-Pinilla E; Marín-López A; Ortego J; Chambers AC; King LA; Castillo-Olivares J
Vaccine; 2018 Nov; 36(46):7003-7010. PubMed ID: 30309744
[TBL] [Abstract][Full Text] [Related]
14. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
[TBL] [Abstract][Full Text] [Related]
15. Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine.
Powell DG; Dwyer RM; Traub-Dargatz JL; Fulker RH; Whalen JW; Srinivasappa J; Acree WM; Chu HJ
J Am Vet Med Assoc; 1997 Jul; 211(2):193-8. PubMed ID: 9227750
[TBL] [Abstract][Full Text] [Related]
16. Immune response of horses to inactivated African horse sickness vaccines.
Rodríguez M; Joseph S; Pfeffer M; Raghavan R; Wernery U
BMC Vet Res; 2020 Sep; 16(1):322. PubMed ID: 32873300
[TBL] [Abstract][Full Text] [Related]
17. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
18. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
von Teichman BF; Dungu B; Smit TK
Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice.
O'Kennedy MM; Roth R; Ebersohn K; du Plessis LH; Mamputha S; Rutkowska DA; du Preez I; Verschoor JA; Lemmer Y
PLoS One; 2024; 19(4):e0301340. PubMed ID: 38625924
[TBL] [Abstract][Full Text] [Related]
20. Development of a Luminex-Based DIVA Assay for Serological Detection of African Horse Sickness Virus in Horses.
Sánchez-Matamoros A; Nieto-Pelegrín E; Beck C; Rivera-Arroyo B; Lecollinet S; Sailleau C; Zientara S; Sánchez-Vizcaíno JM
Transbound Emerg Dis; 2016 Aug; 63(4):353-9. PubMed ID: 27090377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
